How low is the α/β ratio for prostate cancer?
Recently, low α/β values of 1.2 and 1.5 Gy for prostate tumors have been derived from clinical results of external beam radiotherapy and of permanent implants of 125I and 103Pd. In the analyses the contributions of tumor repopulation, and edema as a result of inserting radioactive seeds in the prost...
Saved in:
Published in | International journal of radiation oncology, biology, physics Vol. 57; no. 4; pp. 1116 - 1121 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
New York, NY
Elsevier Inc
15.11.2003
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Recently, low α/β values of 1.2 and 1.5 Gy for prostate tumors have been derived from clinical results of external beam radiotherapy and of permanent implants of
125I and
103Pd. In the analyses the contributions of tumor repopulation, and edema as a result of inserting radioactive seeds in the prostate, have been ignored. In this paper we reanalyzed the clinical data and introduced the contribution of repopulation and edema.
The linear quadratic–biologically effective dose model was used for reanalysis. In this model, the influence of repopulation and edema has been taken into account. The biologically effective dose was calculated as a function of α/β for 2 brachytherapy regimens with
125I and
103Pd and 2 fractionated treatments, and for different half-times for repair of sublethal damage for the brachytherapy regimens.
We have found a plausible α/β value of 3.1 to 3.9 Gy, an α value of 0.1 to 0.15 Gy
−1, and a half-time of repair of about 0.5 h.
It seems now that the α/β value is low, 3.1–3.9 Gy, but not as low as the 1.2 and 1.5 Gy reported earlier. |
---|---|
ISSN: | 0360-3016 1879-355X |
DOI: | 10.1016/S0360-3016(03)01455-X |